Impact of Pembrolizumab Versus Chemotherapy as Second-Line Therapy for Advanced Esophageal Cancer on Health-Related Quality of Life in KEYNOTE-181 This study aims to reconstruct unreported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results